Quadrant Capital Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$474K Buy
4,345
+410
+10% +$39.1K 0.01% 923
2025
Q4
$319K Hold
3,935
0.01% 1132
2025
Q3
$344K Sell
3,935
-11
-0.3% -$982 0.01% 1065
2025
Q2
$328K Sell
3,946
-14
-0.4% -$1.17K 0.01% 1094
2025
Q1
$332K Buy
3,960
+3,619
+1,061% +$337K 0.01% 1013
2024
Q4
$31.4K Hold
341
﹤0.01% 1679
2024
Q3
$31.7K Hold
341
﹤0.01% 1697
2024
Q2
$28.1K Hold
341
﹤0.01% 1706
2024
Q1
$22.6K Buy
341
+12
+4% +$740 ﹤0.01% 1794
2023
Q4
$18.7K Buy
329
+228
+226% +$11.9K ﹤0.01% 1853
2023
Q3
$5.5K Hold
101
﹤0.01% 2145
2023
Q2
$6.8K Buy
101
+28
+38% +$1.71K ﹤0.01% 2129
2023
Q1
$3.76K Buy
73
+20
+38% +$971 ﹤0.01% 2294
2022
Q4
$2.44K Sell
53
-45
-46% -$2.11K ﹤0.01% 2361
2022
Q3
$5K Buy
98
+27
+38% +$1.35K ﹤0.01% 2138
2022
Q2
$3K Buy
71
+46
+184% +$2.06K ﹤0.01% 2119
2022
Q1
$1K Hold
25
﹤0.01% 2333
2021
Q4
$1K Hold
25
﹤0.01% 2332
2021
Q3
$1K Sell
25
-4
-14% -$225 ﹤0.01% 2335
2021
Q2
$2K Buy
29
+4
+16% +$212 ﹤0.01% 2114
2021
Q1
$1K Hold
25
﹤0.01% 2243
2020
Q4
$1K Hold
25
﹤0.01% 2140
2020
Q3
$1K Hold
25
﹤0.01% 2009
2020
Q2
$1K Hold
25
﹤0.01% 2079
2020
Q1
$1K Buy
+25
New +$772 ﹤0.01% 2009

Other funds holding LMAT

Quadrant Capital Group's LMAT Position: Q1 2026 in Review

Quadrant Capital Group increased its LeMaitre Vascular (LMAT) stake by 10% in Q1 2026, buying an estimated $39.1K and bringing the position to 4,345 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #923.

Quadrant Capital Group first reported a position in LMAT in Q1 2020 and has held it in 25 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Quadrant Capital Group held 4,345 shares of LeMaitre Vascular worth $474K as of Q1 2026.
  • Quadrant Capital Group bought 410 LeMaitre Vascular shares in Q1 2026, an estimated $39.1K.
  • LeMaitre Vascular made up 0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #923 holding.
  • Quadrant Capital Group first reported a position in LeMaitre Vascular in Q1 2020 and has held it in 25 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.